Report Categories
View AllRecent Articles
View All
UK Chancellor Reeves Announces VAT Cut for Theme Parks and Childrens Meals to Ease CostofLiving Pressures
Jobless Claims Hold Near Historic Lows Pointing to Resilient Labor Market
Manchesters Defining Spirit How Andy Burnhams Economic Philosophy Could Shape UK Policy
Bond Market Signals Inflation Concerns as Warsh Assumes Fed Leadership
Market Expert Ganesh Dongre Identifies Potential Stock Opportunities Amid Middle East Tensions
IBM Surges on 2 Billion Federal Quantum Computing Boost Adds 27 Billion in Market Value
ORCL Q1 2026 Earnings EPS Beats Estimates as Cloud Momentum Continues
AERT Q1 2026 Earnings EPS Breaks into Positive Territory Stock Rallies
Cerus Corporation CERS Q1 2026 Earnings EPS Surprises to the Upside as Loss Narrows
Alto Ingredients ALTO Q1 2026 Earnings Strong Profit Surprise Drives Share Rally
SOWG Q3 2025 Earnings Significant EPS Miss Overshadows Quarter
QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies
Ford Motor Company Gains 26 as Shares Approach Resistance at 1609
Ladder Capital Corp LADR Holds Steady Near 1024 as Momentum Builds
Professional Diversity Network IPDN Rises 346 as Shares Test Key Resistance at 070
Sow Good Inc SOWG Slips 5 as Stock Tests Key Support Level
CNB Financial Corporation CCNE Shows Modest Gain Consolidating Near Key Levels
External Links
Alight Expands Health Solutions Network Through New Strategic Partnerships
OPTT Q1 2026 Earnings EPS Misses Estimates Shares Gain Slightly
Takeda Pharmaceutical TAK Faces Resistance at 1673 Slips 2 Amid Sector Weakness
Dr Reddys Laboratories RDY Slips 124 as Stock Tests Key Support Levels
Rentokil Initial RTO Moves Modestly Higher Holding Above Key Support
Crane Harbor Acquisition Corp II Rights CRANR Drifts Sideways at 021 Support and Resistance Tighten
VivoPower VIVO Slides 95 as Selling Pressure Intensifies
K Wave Media Ltd KWM Edges Higher Amid Consolidation Near Key Support
Capital Bancorp Inc CBNK Holds Steady Near Key Resistance After Marginal Decline
Axsome Therapeutics Holds Near Resistance as Biotech Sector Shows Mixed Signals